KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $2.3 billion.

  • Abbott Laboratories' Prepaid Assets rose 511.63% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 511.63%. This contributed to the annual value of $2.6 billion for FY2024, which is 1391.84% up from last year.
  • Per Abbott Laboratories' latest filing, its Prepaid Assets stood at $2.3 billion for Q3 2025, which was up 511.63% from $2.3 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Prepaid Assets high stood at $2.8 billion for Q3 2022, and its period low was $2.0 billion during Q1 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $2.3 billion (2024), whereas its average is $2.3 billion.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 3102.16% in 2022, then tumbled by 1528.35% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Prepaid Assets stood at $2.3 billion in 2021, then increased by 13.51% to $2.7 billion in 2022, then fell by 15.28% to $2.3 billion in 2023, then increased by 13.92% to $2.6 billion in 2024, then fell by 12.06% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.3 billion for Q2 2025, and $2.3 billion during Q1 2025.